GT Solar Releases New Version of Multi-crystalline Ingot Growth System

GT Solar International has declared the commercial availability of its latest version of DSS650 multi-crystalline ingot growth systems for use in solar PV industry. The new system develops ingots of more than 600 kilograms with similar dependability and quality of performance, currently available in its other multi-crystalline growth furnaces.

GT Solar has utilized its sophisticated R&D facility and its extensive crystalline growth expertise to make certain about the dependability and performance of its new PV crystalline growth furnaces. The new DSS650 manufactures large sized ingots up to 600 kilograms with a consistency that is suitable for commercial production in large quantities. The new DSS650 system in addition to reducing the cost of ingot manufacture also assist the producers to lessen wafer operations costs because the tall size of the bricks maximizes the utility of wafer saw beam, thus improving the quality of wafers and the production yield. The DSS650 includes improvements in its proprietary  hot zone technology to perk up the performance of the system and its control in the ingot growth procedure. It also includes a new process formula needed to manufacture large sized ingots in large volumes.

The latest DSS650 systems from GT Solar assist the clients to get good returns from the use of equipment. The company also assists the customers to upgrade their existing DSS furnaces to avail the higher production benefits of DSS650. The company has received its first order from Nexolon, a Korea-based photovoltaic manufacturing company.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.